Management of Genital Itching in Female Patients on Hemodialysis
Diagnostic Considerations
- Xerosis (dry skin) is present in 54‑69 % of patients receiving hemodialysis and markedly lowers the threshold for itch, making it a common contributor to genital pruritus【1】.
- Uremic pruritus may localize to the genital area; a pattern of distribution (e.g., involvement of the back, face, or fistula arm) helps differentiate it from primary vulvovaginal disease【2】.
- Lichen sclerosus classically shows porcelain‑white papules or plaques and may include ecchymotic areas; it causes severe nocturnal itching that disrupts sleep【3】.
Optimizing Dialysis‑Related Factors
- Target a Kt/V of ~1.6; patients with sub‑optimal dialysis adequacy experience higher rates of pruritus【1】.
- Correct calcium‑phosphate imbalance and control secondary/tertiary hyperparathyroidism, as elevated PTH contributes to cutaneous manifestations【1】.
- Routine use of emollients is recommended to treat xerosis, the most frequent skin finding in this population【1】.
Pharmacologic Treatment of Persistent Uremic Pruritus
- Gabapentin 100–300 mg administered after each dialysis session (three times weekly) is the most effective systemic option for chronic uremic pruritus; dose reduction is required because of reduced renal clearance【2】.
- Topical capsaicin 0.025 % cream applied four times daily produced marked relief in 14 of 17 patients in randomized trials【2】.
- Broad‑band UVB phototherapy is effective for patients whose itch persists after 2–4 weeks of optimized dialysis and topical measures【2】.
Management of Confirmed Lichen Sclerosus
- High‑potency topical corticosteroids constitute the first‑line therapy for vulvar lichen sclerosus【3】.
- Patients should be monitored for dyspareunia, erosions, or fissures, which may require additional interventions【3】.
- Trauma to the genital skin should be avoided, as it can exacerbate lichen sclerosus【3】.
Medication Pitfalls in the Dialysis Population
- Cetirizine (10 mg daily) is ineffective for uremic pruritus and should not be used【2】.
- Long‑term sedating antihistamines (e.g., diphenhydramine, hydroxyzine) are discouraged except in palliative settings because they increase the risk of dementia【2】.
- Fexofenadine 180 mg daily does not require dose adjustment in renal impairment and is the preferred non‑sedating antihistamine when needed【4】.
- Calamine lotion and crotamiton cream lack supporting evidence for uremic pruritus and should be avoided【2】.
- Topical doxepin must be limited to ≤8 days, ≤10 % body‑surface area, and ≤12 g total daily to prevent systemic absorption【2】.
Additional Clinical Considerations
- Drug‑induced eruptions should be included in the differential diagnosis of genital itching in dialysis patients【1】.
- Renal transplantation remains the only definitive cure for uremic pruritus, though feasibility varies【2】.
- Severe nocturnal itching that disrupts sleep warrants escalation to systemic therapy (e.g., gabapentin) or phototherapy【3】【2】.